BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 21488210)

  • 1. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
    Li Y; Zhao J; Hölscher C
    CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotective effects of paeonol in a cell model of Parkinson disease].
    Wang H; Geng ZM; Hu ZW; Wang SY; Zhao B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 44(1):30-6. PubMed ID: 25851972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Zileuton, a 5-lipoxygenase inhibitor, attenuates mouse microglial cell-mediated rotenone toxicity in PC12 cells].
    Zhang XY; Chen L; Xu DM; Wang XR; Wang YF; Li CT; Wei EQ; Zhang LH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):273-80. PubMed ID: 24998649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
    Li CT; Zhang WP; Lu YB; Fang SH; Yuan YM; Qi LL; Zhang LH; Huang XJ; Zhang L; Chen Z; Wei EQ
    J Neurosci Res; 2009 Mar; 87(4):991-1001. PubMed ID: 18951527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
    Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
    Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
    Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG
    Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of 5-lipoxygenase in hippocampal CA1 neuronal damage following global cerebral ischemia in rats].
    Chen W; Li C; Zhao J; Zhang X; Han H; Wei E; Zhang L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 42(1):61-6. PubMed ID: 23505109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [5-lipoxygenase inhibitors in asthma therapy].
    Tanaka R
    Nihon Rinsho; 1996 Nov; 54(11):3040-4. PubMed ID: 8950951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
    Sinha S; Doble M; Manju SL
    Bioorg Med Chem; 2019 Sep; 27(17):3745-3759. PubMed ID: 31331653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-lipoxygenase is involved in rotenone-induced injury in PC12 cells].
    Zhang XY; Zhang LH; Li CT; Chen WJ; Zhao JB; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):150-5. PubMed ID: 21488210
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.